OCLS News Alert Oculus Innovative Sciences (OCLS) 0.80 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 4:18 AM

Oculus Innovative Sciences (OCLS) 0.80 $OCLS

Oculus Sciences FQ3 results
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 9:50AM CST

OCLS: 0.80 (-0.01)

Oculus Innovative Sciences' Q3 fiscal 2015 net loss widens to USD5.9m
M2 - Fri Feb 13, 4:58AM CST
Pharmaceutical company Oculus Innovative Sciences (Nasdaq:OCLS) disclosed on Thursday that it recorded a net loss of USD5.9m for the third quarter of fiscal year 2015 that ended 31 December 2014.
OCLS: 0.80 (-0.01)

Oculus' (OCLS) CEO Jim Schutz on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 5:54PM CST

OCLS: 0.80 (-0.01)

Oculus Innovative Sciences (OCLS) Q3 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 12, 3:25PM CST

OCLS: 0.80 (-0.01)

Oculus Innovative Sciences EPS of -$0.69
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 3:13PM CST

OCLS: 0.80 (-0.01)

Oculus Innovative Sciences Reports Financial Results for the Third Quarter of Fiscal Year 2015
GlobeNewswire - Thu Feb 12, 3:09PM CST
-- Total revenue of $3.2 million for the third quarter
RTGN: 4.20 (+0.08), OCLS: 0.80 (-0.01)

Biotech Weekly: When To Dash For The Trash (And When Not To)
Daniel Ward - at Seeking Alpha - Mon Feb 02, 8:40AM CST

KBIO: 0.45 (+0.06), CYCC: 0.62 (-0.01), TRGT: 2.50 (-0.01), SPHS: 0.44 (-0.01), ABIO: 0.70 (+0.03), APPY: 0.45 (-0.01), OCLS: 0.80 (-0.01)

Oculus Innovative Sciences Announces Fiscal Third Quarter 2015 Financial Results and Conference Call
GlobeNewswire - Thu Jan 29, 4:04AM CST
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced that the financial results for its fiscal third quarter 2015, ended December 31, 2014, will be released after the U.S. markets close on February 12, 2015. The earnings release will be followed by a conference call at 1:30 p.m. PT on February 12, 2015, to discuss fiscal third quarter results.
OCLS: 0.80 (-0.01)

Oculus Innovative Sciences concludes public offering of common stock and warrants
M2 - Wed Jan 28, 4:21AM CST
Pharmaceutical company Oculus Innovative Sciences (Nasdaq:OCLS) (Nasdaq:OCLSW) disclosed on Tuesday that its has raised gross proceeds from its public offering, including the underwriters' partial exercise of the over-allotment option, of approximately USD6.3m.
OCLSW: 0.25 (unch), OCLS: 0.80 (-0.01)

Oculus Innovative Sciences Announces Closing of $6.3 Million Underwritten Public Offering
GlobeNewswire - Mon Jan 26, 4:50PM CST
Oculus Innovative Sciences, Inc. (Nasdaq: Common Stock - OCLS, Warrants - OCLSW) today announced the closing of its previously announced underwritten public offering of 6,250,000 shares of common stock, and warrants to purchase an aggregate of 4,687,500 shares of common stock, at an offering price of $1.00 per share and related warrant. The warrants have an exercise price of $1.30 per share, and are exercisable for a period of five years beginning January 26, 2015.
OCLS: 0.80 (-0.01)

Oculus Innovative Sciences expects USD6.3m from upsized public offering
M2 - Thu Jan 22, 6:50AM CST
Pharmaceutical company Oculus Innovative Sciences (Nasdaq:OCLS) said on Tuesday that it has priced a higher public offering of 6,250,000 shares of common stock and warrants to purchase an aggregate of 4,687,500 shares of common stock at an offering price of USD1.00 per share and related warrant.
OCLS: 0.80 (-0.01)

Nasdaq stocks posting largest volume increases
AP - Wed Jan 21, 5:01PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
UNAM: 11.75 (-0.10), ADXS: 7.18 (+0.06), TFSC: 9.43 (+0.02), LPHI: 0.23 (unch), VYFC: 19.72 (+0.12), NVC.TO: 11.27 (-0.23), CFNB: 14.10 (+0.28), OCLS: 0.80 (-0.01), NVCN: 9.08 (-0.17), OUTR: 68.39 (+2.22)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Jan 21, 11:45AM CST

FRO: 2.96 (+0.07), ADXS: 7.18 (+0.06), SCOK: 2.83 (-0.18), RNO: 2.73 (+0.07), ACTG: 13.13 (+0.04), ASPS: 22.32 (+0.09), MCEP: 6.29 (+0.12), IMKTA: 42.26 (-0.18), FXCM: 2.21 (-0.01), LPI: 13.25 (+0.81), SSE: 5.23 (+0.22), OCLS: 0.80 (-0.01), NFLX: 466.10 (+9.37), XXII: 0.92 (-0.07), MIL: 4.53 (+0.07), NSP: 48.91 (+1.20), EGO: 4.94 (+0.10), ISDR: 11.79 (+0.01), WHX: 0.61 (+0.06), NXTD: 2.70 (+0.04)

Oculus Innovative Sciences Announces Pricing of Upsized $6.3 Million Underwritten Public Offering
GlobeNewswire - Wed Jan 21, 9:04AM CST
Oculus Innovative Sciences, Inc. (Nasdaq: Common Stock - OCLS, Warrants - OCLSW) today announced the pricing of an underwritten public offering of 6,250,000 shares of common stock, and warrants to purchase an aggregate of 4,687,500 shares of common stock, at an offering price of $1.00 per share and related warrant. The warrants have an exercise price of $1.30 per share, and are exercisable for a period of five years beginning January 21, 2015. The offering was upsized from 5,750,000 shares.
OCLS: 0.80 (-0.01)

Oculus upsizes equity offering
Seeking Alpha - at Seeking Alpha - Wed Jan 21, 8:40AM CST

OCLS: 0.80 (-0.01)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Wed Jan 21, 8:14AM CST

NFLX: 466.10 (+9.37), ANV: 0.97 (-0.03), SCOK: 2.83 (-0.18), EGO: 4.94 (+0.10), WHX: 0.61 (+0.06), DAN: 22.96 (-0.04), SNE: 27.30 (+0.19), ARNA: 4.55 (+0.02), OCLS: 0.80 (-0.01), CREE: 37.51 (+0.08)

Oculus Innovative Sciences to divest Ruthigen shares for USD5.5m in event of Ruthigen merger
M2 - Mon Jan 12, 6:53AM CST
Pharmaceutical company Oculus Innovative Sciences (NasdaqCM:OCLS) reported on Monday the launch of a securities purchase agreement with two current Ruthigen investors.
RTGN: 4.20 (+0.08), OCLS: 0.80 (-0.01)

Oculus Innovative Sciences Enters Into Agreement to Sell Ruthigen, Inc. Shares for $5.5 Million in Event of Ruthigen Merger
GlobeNewswire - Mon Jan 12, 5:35AM CST
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced that the company has entered into a securities purchase agreement with two current Ruthigen investors, under which these two buyers agree to purchase all of Oculus' two million Ruthigen (Nasdaq:RTGN) shares at $2.75 per share, or an aggregate of $5.5 million. The agreement expires in 60 days and is subject to Ruthigen entering into a definitive agreement for a merger.
RTGN: 4.20 (+0.08), OCLS: 0.80 (-0.01)

Oculus creates new dermatology division
Seeking Alpha - at Seeking Alpha - Wed Jan 07, 6:56AM CST

OCLS: 0.80 (-0.01)

Oculus Innovative Sciences Announces New Dermatology Division, IntraDerm Pharmaceuticals
GlobeNewswire - Wed Jan 07, 4:05AM CST
-- Multiple Microcyn(R)-Based Dermatology Products for Management of Pain/Itch and Scar Management Now Commercialized in the United States
OCLS: 0.80 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

LG OLED evo W6: UAE Roadshow Starts with a Bang

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Innventure Faces Major Lawsuit Over Misleading Investors

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Hyliion Class Action Deadline Nears for Investors

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Weifang's Cultural Resurgence: A Global Epigraphy Fest

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

AEVEX Facing Class Action Deadline Amid Stock Turmoil

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Masimo's smartSET™ Revolutionizes Patient Monitoring

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...